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Abstract
Objective—Symptoms of both gastroesophageal reflux disease (GERD) and irritable bowel
syndrome (IBS) are frequently reported by individuals who binge eat. Higher body mass index
(BMI) has also been associated with these disorders and with binge eating (BE). However, it is
unknown whether BE influences GERD/IBS and how BMI might affect these associations. Thus,
we examined the potential associations among BE, GERD, IBS, and BMI.
Methods—Participants were from the Swedish Twin study of Adults: Genes and Environment
(STAGE) and provided information on disordered eating behavior, BMI, gastrointestinal (GI)
disorders, and commonly comorbid psychiatric and somatic illnesses. Key features of GERD and
IBS were identified to create modified definitions of both disorders that were used as primary
outcome variables. Logistic regression models were applied to determine the association between
BE and each GERD/IBS both independently and in the context of BMI and other commonly
comorbid psychiatric and somatic morbidities.
Results—Prevalence estimates for GERD and IBS were higher among women than men (all p-
values < .001). Only the association between BE and IBS was significant in both men and women
after adjustment for BMI and the psychiatric/somatic morbidities.
Conclusion—BE appears to be an important consideration in the presence of IBS symptoms in
both men and women, even when considering the impact of BMI and other commonly comorbid
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conditions. This association underscores the importance of routine assessment of BE in patients
presenting with IBS to effectively manage the concurrent presentation of these problems.
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INTRODUCTION
The association between the behavior of binge eating (BE) and gastrointestinal (GI)
complaints is not well understood. BE is the hallmark feature of two eating disorders—
bulimia nervosa (BN) and binge eating disorder (BED). BN, characterized by recurrent
binge eating and compensatory behaviors (e.g., self-induced vomiting, laxative abuse) has
been associated with several GI symptoms including acid regurgitation, upper abdominal
pain, bloating, and constipation or diarrhea.(1, 2) It is not clear whether the observed GI
symptoms result from these compensatory behaviors or from the increased volume or
composition of food consumed during BE. Further, eating disorder patients with a history of
BE commonly report GI symptoms such as impairment of esophageal motility, delayed
gastric emptying, bloating, and constipation [1, 2].
Two GI disorders frequently reported by individuals with eating disorders (particularly BN
and BED) are gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)
[3, 4]. Preliminary studies suggest that individuals who engage in BE are more likely to
report upper and lower GI symptoms than individuals who do not have episodes of BE [5].
Additionally, the increased stomach capacity among those who report BE [6] may also
negatively impact GI system burden.
The association between BE and GI symptoms is further complicated by increased body
mass index (BMI) in both individuals with BE [7] and in those with a GI disorder [5, 8]. BE
[9], GERD [10], and IBS [11] are all frequently reported in obese individuals. Given the
associations of BE with both obesity and GI disorders, it is plausible that BE could influence
the relationship between BMI and GI disorders.
Thus, the objective of the present study was to investigate the association between BE and
GI symptoms, after controlling for BMI. Based on previous studies, we hypothesized that
BE would be positively associated with the GERD and IBS even when controlling BMI.
METHOD
Participants
Participants were from the Swedish Twin study of Adults: Genes and Environment
(STAGE; http://ki.se/ki/jsp/polopoly.jsp?d=9610&l=en), a large population based study.
STAGE is a subset of the Swedish Twin Registry (STR; http://ki.se/twinreg) and includes
data collected in 2005 from over 25,000 male and female twins between the ages of 20 and
47 years at time of interview (overall response rate = 59.6%). Using web-based
questionnaires with a computer assisted phone option, participants provided information on
a variety of health related and sociodemographic measures as well as habits and behaviors:
43.1% responded using the web-based format exclusively and 16.5% responded exclusively
to telephone format. The eating disorders section demonstrated adequate agreement between
the web-based questionnaire and the telephone interviews (κ = 0.76). A detailed description
of the study design can be found elsewhere [12, 13].
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A total of 23,821 participants provided information in the eating disorder section. Of these,
23,202 reported information on age at interview, lifetime highest BMI (height and weight),
lifetime history of BE (absent or present), and information on GERD or IBS. To be included
in the current study, participants must have provided information on purging, anxiety,
depression, hypertension, lipid disorders, diabetes, Crohn’s disease, and ulcerative colitis
(all defined below); participants missing information for any of these variables were
excluded from analyses (n = 7,934). The resulting sample size available for analyses was
6,827 men and 8,841 women. STAGE was approved by the Regional Ethics Committee at
Karolinska Institutet and is in accord with the Declaration of Helsinki. The current study
was approved by the Biomedical Institutional Review Board at the University of North
Carolina at Chapel Hill. All participants provided informed consent prior to participation.
Disordered Eating Behaviors
Lifetime history of BE and purging was determined using an expanded Structured Clinical
Interview for the Diagnostic and Statistical Manual, Fourth Edition (SCID)–based
assessment [14]. For the purposes of this study, BE was assessed using the following two
questions: “Have you ever had eating binges when you ate what most people would regard
as an unusually large amount of food in a short period of time?” (‘yes,’ ‘no,’ and ‘do not
know/refuse’) and “When you were having eating binges, did you feel that your eating was
out of control?” (‘not at all,’ ‘slightly,’ ‘somewhat,’ ‘very much,’ ‘extremely,’ ‘do not know/
refuse’). BE was scored as present if respondents answered ‘yes’ to the first question and
any loss of control to the second question. If respondents answered ‘no’ to the first question
or ‘not at all’ to the second question, BE was scored as absent.
Purging was defined as engaging in self-induced vomiting and or laxative abuse.
Participants were asked, “Which of the following have you ever used to control your shape
or weight?” Response options were ‘never,’ ‘once or twice,’ ‘every week,’ or ‘daily.’ Those
who responded ‘every week’ or ‘daily’ to either self-induced vomiting or laxative use were
scored as positive for purging. In addition, if a participant indicated that s/he had eating
binges as defined above, s/he was asked if s/he engaged in self-induced vomiting or laxative
use during the time of binge eating. Those who responded ‘yes’ for either self-induced
vomiting or laxative use were scored as positive for purging.
BMI Category
BMI (kg/m2) was calculated using self-reported height and highest self-reported weight (i.e.,
lifetime highest BMI). For the purposes of this study, BMI was categorized according to
World Health Organization guidelines as follows: Underweight < 18.50; Normal weight =
18.50–24.99; Overweight = 25.00–29.99; Obese ≥ 30.00 [15].
GI Problems
The primary outcome variables for the current study include symptoms of GERD as
determined by the Montreal definition and classification [16] and IBS as determined by the
Rome criteria [17]. Participants were asked a series of questions evaluating the presence of
GERD and IBS symptoms including its presence (e.g., “Have you ever had Symptom X”)
and the frequency of that symptom (e.g., “How often do you have Symptom X”). Two
definitions of GERD were used in this study: a broad definition and a more specific
definition that included an assessment of sleep disturbance. If a respondent reported frequent
(> once per month) pain behind the sternum or frequent acid reflux s/he was scored as
positive for “GERD broad.” For “GERD sleep,” if a respondent reported frequent pain
behind the sternum or frequent acid reflux and also reported awakening at night due to pain
or discomfort behind the sternum, s/he was scored as positive. Similarly, IBS was evaluated
using three definitions: 1) recurrent abdominal pain alleviated after defecation (IBS broad);
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2) recurrent abdominal pain occurring at least seven days per month and in the last year that
is alleviated after defecation (IBS narrow); and 3) meeting criteria for IBS broad and
endorsing either feeling bloated, having constipation, diarrhea, or an incomplete feeling of
defecation (IBS cumulative).
Covariate Selection
Age at interview was included as a covariate in all models because there is an age-related
association between BMI and GERD and IBS symptoms [18, 19]. Purging was also included
as a covariate in all models in an effort to control for any effects of self-induced vomiting or
laxative abuse. In addition, selected psychiatric and medical disorders were considered for
inclusion as covariates in the models. Given the demonstrated association between anxiety
and depression and both GERD [20] and IBS [21], both psychiatric disorders were evaluated
as covariates. Generalized anxiety disorder was considered present for all individuals who
reported both DSM-IV-TR Criterion A (excessive anxiety and worry) and Criterion C (at
least three symptoms resulting from anxiety and worry). Depression was similarly defined:
individuals who reported both DSM-IV-TR Criterion A (five symptoms of depression
associated with a change in functioning) and Criterion C (significant impairment caused by
the symptoms) were scored as positive for depression. Given the overlap in some symptom
presentations of both ulcerative colitis and Crohn’s disease and IBS [22], participants who
reported these symptoms were excluded from the analyses (n = 138). Additionally,
hypertension, lipid disorders, and diabetes have demonstrated associations with BMI [23],
therefore these conditions were also evaluated as covariates. To assess these conditions in
the current study, participants were asked, “Do you have or have you ever had any of the
following problems?” and were instructed to respond ‘yes’ or ‘no’ to each disorder in a list
which included Crohn’s disease, ulcerative colitis, hypertension, lipid disorders, and
diabetes.
Anxiety, depression, hypertension, lipid disorder, and diabetes were first evaluated
individually for their association with each GI symptom cluster (e.g., GERD broad, GERD
sleep, IBS broad, IBS narrow, IBS cumulative) using logistic regression models with
generalized estimating equations without correcting for multiple comparisons. Those that
were significantly associated with each GI symptom cluster were included in the analytic
models described below.
Statistical Analysis
SAS software (version 9.2) from SAS institute Inc., 2008 [24] was used to perform data
analysis. Percent frequencies and means with respective standard deviations were calculated
for sample descriptive statistics. Sex differences in the GI outcomes and binge eating were
evaluated with chi-square statistics. To evaluate the association of BE with each GI
symptom cluster, BE was entered into a logistic regression model as a single predictor. A
binge eating x sex interaction was also evaluated in the unadjusted initial models. The
interaction was significant in a majority of the models, thus the association between binge
eating and each of the GI symptom clusters was evaluated separately by sex. In the second
model, anxiety, depression, hypertension, lipid disorders, and diabetes were added as
covariates. Lastly, BMI was added in as a covariate in the final model. Generalized
estimating equations were applied to account for the non-independence of the data due to
inclusion of twins within the same families. To control type I error inflation, p-values were
corrected for multiple comparisons using the methods of false discovery rate and families of
tests were separated by sex [25]. All corrected p-values < .05 were considered statistically
significant.
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Prevalence of GI symptom clusters, covariates, and BMI categories
In the current sample, the prevalence estimates were: GERD broad (men = 15.7%; women =
28.9%; χ2 = 352.12, df = 1, p < .001), GERD sleep (men = 5.5%; women = 12.3%; χ2 =
207.65, df = 1, p < .001), IBS broad (men = 3.7%; women = 8.1%; χ2 = 115.06, df = 1, p <.
001), IBS narrow (men = 1.7%; women = 4.2%; χ2 = 78.78, df = 1, p < .001) and IBS
cumulative (men = 3.1%; women = 7.6%; χ2 = 135.13, df = 1, p < .001). Due to these
significant sex differences, all analyses were conducted separately by sex. Tables 1 and 2
provide descriptive information regarding the prevalence of each of the GI symptom
clusters, the associated covariates, and BMI categories.
The association of BE, medical and psychiatric covariates, and BMI category with GI
symptom clusters
In men, there was a significant positive association between BE and each of the GI symptom
clusters (see Figure 1). However, as the covariates were introduced into the model, the
associations between BE and GERD sleep (OR = 3.33, fdr-p < .05), IBS broad (OR = 3.83,
fdr-p < .05), IBS narrow (OR = 6.23, fdr-p < .01), and IBS cumulative (OR = 4.54, fdr-p < .
01) remained significant. When BMI was introduced into the model only the IBS symptom
clusters remained significant (IBS broad OR = 3.84, fdr-p < .05, IBS cumulative OR = 4.61,
fdr-p < .01, and IBS narrow OR = 6.30, fdr-p < .01).
There was a similar pattern of results for women in the current sample (see Figure 1). The
initial main effect of BE was significant across all GI symptom clusters (all fdr-p values < .
001), even in the context of the identified covariates (all fdr-p values < .05). However, when
BMI was introduced into the model, only IBS broad (OR = 1.88, fdr-p < .01), IBS
cumulative (OR = 1.94, fdr-p < .01) and IBS narrow (OR = 1.84, fdr-p < .05) remained
significant.
DISCUSSION
Prevalence estimates of GERD and IBS symptom clusters in the current study ranged are
somewhat lower than those reported in previous studies in the Western world (in both men
and women) [26, 27]. The dissimilarities in these prevalence estimates may be suggestive of
true differences among individuals reporting GI symptoms in Sweden; however, it is
possible that the lower prevalence was influenced by an overall lower BMI among
participants in this cohort. The majority of individuals in the current sample fell within a
normal BMI range (18.50 – 24.99 kg/m2) and given the demonstrated effect of weight on
both GERD [10] and IBS [11], it is possible that the lower prevalence of the GI symptoms in
this study reflected this fact. Alternatively, it is possible that the lower prevalence of GERD
in our study is reflective of a difference among Swedish men as one recent study failed to
find any significant association between BMI and GERD symptoms in this group [28].
Despite these differences, GERD and IBS were reported among a sizeable proportion of
individuals in the sample, and this was particularly true for reports of GERD among women.
The significant, positive association between BE and IBS symptoms, which persisted even
after introducing potential medical and psychiatric morbidities (e.g., hypertension, Crohn’s
disease, depression) and BMI, suggests that the influence of BE is particularly robust. Given
the exploratory nature of the current analyses we present three potential interpretations of
the underlying association between BE and IBS. First, both BE and IBS have demonstrated
important relationships with psychosocial stress [29–31]. Stress is known to be a common
precipitant of BE [29] and many individuals who struggle with this behavior may be prone
to using BE in an effort to reduce anxiety or dysphoria [31]. In addition, stress is thought to
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play an important etiological role in functional GI disorders (the most common of which is
IBS) [30, 32–35]. The observed association could potentially reflect a pattern that would be
expected to occur if stress were a critical third variable that influenced both BE and IBS.
While the current analyses do not lend themselves to mediation to assess the influence of
stress, such analyses would be important to undertake in future studies.
A second hypothesis is that the acute symptoms of IBS (e.g., nausea, diarrhea) may cause
patients to either severely restrict their diets so as to avoid specific foods or to undergo
prolonged periods of restriction to avoid IBS flares. Given the known association between
dietary restriction and urges to binge [36], the observed association might suggest an
inadvertent side effect of attempts to avoid IBS episodes via food restriction or limitation.
A third hypothesis is that individuals with concurrent BE and IBS may experience acute
symptoms of IBS as a result of bingeing on foods that are not well tolerated. Symptoms of
IBS are often triggered by food intolerance, particularly with foods that are high in fat
content [37–39]. Macronutrient studies of those who engage in BE reveal that typical binge
episodes are dense with high-fat foods and carbohydrates [40]. Thus, patients who struggle
with BE may be more prone to IBS flare ups given that their binges are likely to be rich with
foods that are poorly tolerated due to IBS. The design of the current study precluded testing
of these alternative explanations for our observation; however, it will be important for future
studies to examine the role of stress, food avoidance/fasting, and macronutrient content in
the association between BE and IBS. Examination of the temporal sequencing of IBS and
BE onset will be particularly relevant given our limited understanding of the association
between these variables.
Thus, the current pattern of results underscores the importance of the regular evaluation of
BE in the context of IBS. Not only was BE reported among a sizeable portion of the sample,
BE was more likely in those reporting both GERD and IBS even when purging was
controlled statistically. Given this significant finding, it is prudent to consider screening for
BE as a regular part of GERD and IBS evaluations, especially among women. This is
particularly salient as recent estimates have suggested that BED is the most common of all
eating disorder pathology with estimates as high as 3.5 percent among women and 2.0
percent among men in the United States [41].
The current findings also have important implications for the management of patients who
are reporting concurrent BE and GI symptoms. Interventions for IBS should not only focus
on the alleviation of symptoms like abdominal pain and diarrhea, but also on the elimination
of any concurrent BE. It stands to reason that depending on the causal relationships between
BE and IBS, it is possible that as BE improves, a reduction in IBS symptoms and/or severity
might occur. A combined medical and behavioral treatment plan would require a
multidisciplinary approach common to many GI practices throughout the world given the
frequently associated psychological factors that can exacerbate many GI disorders [42]. In
the case of BE, however, it would be sensible to ensure that patients are receiving
psychological care from eating disorder specialists who are trained in the management of
eating pathology. In fact, regular screening of eating pathology in GI clinics could help
facilitate an appropriate referral and perhaps expedite the treatment process for patients
struggling with concurrent BE and GI symptoms.
Limitations
Although the current study provides important insights regarding the role of BE in the
relationship between BMI and GI symptoms, there are a number of notable limitations. First,
the population surveyed in the present sample was Swedish men and women thus the results
might not generalize to other ancestry groups. Second, although the current data were
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derived from a large, population-based register, it is possible that the results are not entirely
representative of the population given that the initial response rate was 59.6%. Third, the
report of loss of control with regard to BE was rarely reported among Swedish men. This
lack of reporting might reflect the true experience of Swedish men; however it is also
possible that the construct was not defined in a way that resonated with the population being
sampled. Thus our estimates of BE among men are likely to be biased given the relatively
infrequent report of loss of control eating. Fourth, the data analyzed in this study were cross-
sectional and the time span corresponding to reported symptoms is not consistent across
measures. For example, BE, anxiety, depression, and BMI were assessed over the lifetime,
whereas GI symptoms (including those consistent with GERD and IBS) reflected an
individual’s current status. It is therefore important to recognize that the associations
elucidated here are correlational in nature and causal inference cannot be drawn. The time
span discrepancies in the data collection also necessitate caution when interpreting the
correlational findings. This limitation highlights the importance of longitudinal research
designs in determining the nature of the associations between BE, BMI, and GI symptoms.
Fourth, the GI symptom clusters used for the current study do not reflect full diagnoses of
GERD or IBS. Although the symptom criteria used to describe each cluster were drawn
from established definitions and diagnostic guidelines, it is possible that the selection of
other criteria might have resulted in a different outcome. Future studies would benefit from
assessing full diagnostic criteria for both GERD and IBS to further evaluate the potential
impact of BE on these diagnoses. Finally, the data collected for the current study did not
differentiate between Type 1 or Type 2 diabetes and thus we are unable to determine the
extent to which either presentation independently might have influenced the results. It will
be important for future studies to assess specific diabetes diagnoses and how each might
affect the association between BE and GI disorders.
The results of the current study provide empirical support for an association between BE and
GI symptoms consistent with IBS in both men and women. This study is novel in its
approach in that we were able to assess the independent effect of BE while controlling for
any potential impact that purging might introduce. Thus the results shed new light on a
previously understudied phenomenon and provide direction for future research and clinical
interventions. Empirical investigations that apply longitudinal designs and integrate full
diagnoses of GERD and IBS are necessary to understand the impact of BE more fully. It will
also be necessary to evaluate the nature of these associations in men and women of other
racial and ethnic backgrounds given that GI symptoms consistent with these disorders have
been shown to disproportionately affect individuals of African American and Hispanic
descent [43–45]. The current findings suggest that clinical practice might also benefit from a
more regular screening of BE when evaluating GERD and IBS. Additionally, management
of any relevant BE should be incorporated in designing and tailoring treatment interventions
given that the continued presence of this behavior may exacerbate symptoms or prevent
optimum treatment outcomes.
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Odds Ratio of Gastrointestinal (GI) Outcomes by Binge Eating (BE) Status.
aNote. The dots represent odds ratios and the intervals represent 95% confidence intervals.
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